Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vertex Pharmaceuticals Inc.

www.vrtx.com

Latest From Vertex Pharmaceuticals Inc.

Coronavirus Update: Vertex, Pfizer And Others Disclose Trial Disruptions, Viatris Merger Delayed

Clinical trials in a range of diseases continue to be impacted by concerns about patient safety and health care resources as the COVID-19 pandemic grows.

Coronavirus COVID-19 Clinical Trials

ReCode Combines With TranscripTx, Raises $80m For Novel RNA Drugs

ReCode, whose platform allows for organ-specific delivery of RNA therapies, plans to start clinical trials in 2022 for its two lead programs in primary ciliary dyskinesia and cystic fibrosis.

StartUps and SMEs Drug Delivery

Underserved Areas: Looking Beyond Cancer And Rare Diseases

Oncology and rare diseases dominate the industry pipeline, fuelled by science, regulatory tailwinds and high prices. But as the world grapples with coronavirus, and with heart disease still the top killer, can our systems fund treatments for more prevalent conditions?

Clinical Trials Research and Development Strategies

How To Win Corporate Approval For Process Analytical Technologies

Why Pfizer, Vertex and Biogen executives green-lighted investments in technologies to check seal integrity, ingredient dryness and other process attributes.

Manufacturing Quality
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Vertex Pharmaceuticals Inc.
  • Senior Management
  • Jeffrey Leiden, MD, PhD, Chmn., Pres. & CEO
    Charles F Wagner, EVP, CFO
    Stuart A Arbuckle, EVP, Chief Commercial Officer
    David Altshuler, MD, PhD, EVP, Global Research & CSO
    Reshma Kewalramani, MD, EVP, Global Medicines Dev. & Medical Affairs & CMO
  • Contact Info
  • Vertex Pharmaceuticals Inc.
    Phone: (617) 444-6100
    50 Northern Ave.
    Boston, MA 02210
    USA
UsernamePublicRestriction

Register